Fund moves

Roivant Sciences (ROIV): SB Investment Advisers (UK) Ltd reduced its stake -13.74M shares

SB Investment Advisers (UK) Ltd reduced its stake in Roivant Sciences, per its Q1 2026 13F.

2.67M
Shares reported · -13.74M vs prior quarter
0.96%
Disclosed portfolio weight
$74M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 18, 2026

What stands out in this filing

  • 16,413,603 shares in Q4 2025, 2,671,732 now (−83.7% in share count).
  • Reported at $74M, 0.96% of the portfolio value in this 13F filing.
  • 10 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
  3. Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
  4. Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
  5. Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  6. Apr 8, 2026InsiderOfficer sold ~$384K of ROIV shares in the open market
  7. Apr 16, 2026InsiderCEO sold ~$8.45M of ROIV shares in the open market
  8. Apr 20, 2026InsiderCEO sold ~$5.92M of ROIV shares in the open market

What came next

  1. May 20, 2026Company filing · Form 8-K · ResultsReported its results
  2. May 22, 2026InsiderCEO sold ~$6.05M of ROIV shares in the open market
  3. Jun 24, 2026Insider · 1 personInsiders: 2 sales (~$6.6M)
  4. Jun 25, 2026InsiderDirector sold ~$17.1M of ROIV shares in the open market
  5. Jun 26, 2026Insider · 4 peopleInsiders: 7 sales (~$80.9M)
  6. Jun 29, 2026Insider · 4 peopleInsiders: 8 sales (~$83.5M)
  7. Jun 30, 2026Insider · 4 peopleInsiders: 5 sales (~$8.7M)
  8. Jul 27, 2026InsiderCEO sold ~$6.99M of ROIV shares in the open market
  9. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  10. Aug 14, 2026InsiderDirector sold ~$8.81M of ROIV shares in the open market
  11. Aug 17, 2026InsiderDirector sold ~$10.3M of ROIV shares in the open market
  12. Aug 18, 2026Insider · 1 personInsiders: 2 sales (~$5.0M)
  13. Aug 19, 2026InsiderDirector sold ~$6.43M of ROIV shares in the open market
  14. Aug 20, 2026InsiderDirector sold ~$653K of ROIV shares in the open market
  15. Aug 21, 2026InsiderDirector sold ~$5.28M of ROIV shares in the open market
  16. Aug 28, 2026Insider · 1 personInsiders: 2 sales (~$7.2M)
  17. Sep 8, 2026InsiderDirector sold ~$798K of ROIV shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

How this filing works

Explore the data

Common questions

What does this filing report about Roivant Sciences (ROIV) stock?

SB Investment Advisers (UK) Ltd reduced its stake in Roivant Sciences, per its Q1 2026 13F. Now 2.67M shares, $74M reported value, 0.96% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 18, 2026.

What stands out in this filing?

16,413,603 shares in Q4 2025, 2,671,732 now (−83.7% in share count). Reported at $74M, 0.96% of the portfolio value in this 13F filing. 10 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Roivant Sciences recently?

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.

Does this mean ROIV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data